History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Cycle for Survival Fred's Team Rock & Run on the River Yankees Universe Fund Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck CELEBRATIONS
Press Releases In the News Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days IS Careers Job Search & Apply Online
Making an Appointment
New Chemotherapy Treatment Used for Basketball Star's Daughter
The story of Utah Jazz star Derek Fisher's daughter and her groundbreaking retinoblastoma treatment, administered by Memorial Sloan-Kettering's David Abramson and Pierre Gobin of NewYork-Presbyterian Hospital.

We have introduced a new treatment for certain patients, in which chemotherapy is injected around the eye instead of being given intravenously. This can be more effective and also avoids some of the side effects of intravenous chemotherapy. This new treatment is discussed in greater detail in the October 1999 issue of the journal Ophthalmology [Abstract].

Our team was the first to use a new laser delivery method known as a diopexy probe, which enables treatment of the cancer by aiming the light through the wall of the eye and not through the pupil.

For those patients whose retinoblastoma has spread to the surface of the brain, our team has had success using a new medication that is delivered directly into the fluid that surrounds the brain and spinal cord.

Recently, working in collaboration with physicians from Weill Cornell University Medical Center, our team used a technique known as preimplantation genetic testing in families at risk for having children with inherited retinoblastoma. After fertilizing 20 embryos from one couple using standard in vitro fertilization techniques, doctors tested each embryo for the mutation. Five of the embryos that were found to be free of the mutation were implanted in the mother's womb, resulting in the successful birth of a single, retinoblastoma-free child. The team has since repeated this success with another mother and child.

Our Clinical Trials

Retinoblastomatop
Last Updated: Jan. 17, 2006
Bookmark and SharePrintEmail This Page